New York City’s preeminent Icahn School of Medicine at Mount Sinai, Department of Medicine’s Clinical Trials Office (CTO) and collaborative […]
Remdesivir is the only therapy in the United States approved, under emergency use status, as a treatment for COVID-19 along […]
Recently, the Wall Street Journal introduced a small, 25-person San Diego-based biotech called Ansun Biophrma (Ansun) reporting on recent success of […]
Virginia Commonwealth University (VCU), a prominent public research university in Richmond, Virginia, became one of the first clinical investigational sites […]
Aridis Pharmaceuticals, Inc (NASDAQ: ARDS) announced the enrollment of its first COVID-19 patient in an ongoing Phase III clinical trial […]
The valley where the Tigris and Euphrates Rivers flows down through what is now modern-day Iraq is literally a cradle of […]
Roche recently announce the launch of a global study in collaboration with the U.S. Biomedical Advanced Research and Development Authority […]
Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe […]
Polyphor has temporarily halted enrollment for the pivotal Phase III trials PRISM-MDR and PRISM-UDR, which are evaluating murepavadin in patients […]
COMBACTE-NET, the European consortium, has completed the Phase II SAATELLITE clinical trial of AstraZeneca’s anti-infective drug suvratoxumab to prevent ventilator-associated […]
